亚辉龙被证监会立案调查，受损股民可索赔

Core Viewpoint - Shenzhen Yahui Long Biotechnology Co., Ltd. (stock code: 688575) has received a notice from the China Securities Regulatory Commission (CSRC) regarding a formal investigation for suspected violations of information disclosure laws [1] Group 1: Investigation Details - The CSRC has decided to initiate a formal investigation against the company due to alleged violations of the Securities Law of the People's Republic of China and the Administrative Penalty Law [1] - The company will actively cooperate with the CSRC during the investigation and will adhere to regulatory disclosure obligations [1] - As of the announcement date, the company has not received a final conclusion from the CSRC regarding the investigation [1] Group 2: Investor Compensation - Investors who purchased Yahui Long shares between the listing date and February 7, 2026, and either held or sold the shares after February 8, 2026, may be eligible for compensation [2] - The initial compensation conditions are subject to confirmation by the court's effective judgment [2] - Required documentation for compensation includes original transaction statements, copies of investor identification, and confirmation of securities account information from the brokerage [3]